Investigators want to know if increasing the oxygen concentration in the tumor might lend standard therapies a boost. Early results show promise. Phase II of a long-term clinical trial in Japan, published March 17 in the International Journal of Radiation Oncology • Biology • Physics, concludes:
Radiotherapy delivered immediately after HBO with multiagent chemotherapy was safe, with virtually no late toxicities, and seemed to be effective in patients with high-grade gliomas.
Previous studies out of Japan showed similar benefit. Another Phase II study, the first in the US, at the Long Island Brain Tumor Center in Great Neck and Commack, New York, is currently recruiting participants. Learn more about enrolling on ClinicalTrials.gov and read more about this important work in Medical News Today.
O2.0 is the news blog of HyperbaricLink, the independent web guide to hyperbaric oxygen therapy.